BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24047214)

  • 1. Discovery of novel lead in the group of N-substituted piperazine ether derivatives with potential histamine H3 receptor activity.
    Kuder KJ; Stachnik M; Schunack W; Szymańska E; Kieć-Kononowicz K
    Med Chem; 2014; 10(6):588-99. PubMed ID: 24047214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel steroidal histamine H
    Ledneczki I; Tapolcsányi P; Gábor E; Éles J; Greiner I; Schmidt É; Némethy Z; Kedves RS; Balázs O; Román V; Lévay G; Mahó S
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4525-4530. PubMed ID: 28888822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands.
    Geyer R; Kaske M; Baumeister P; Buschauer A
    Arch Pharm (Weinheim); 2014 Feb; 347(2):77-88. PubMed ID: 24493592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H
    Szczepańska K; Karcz T; Mogilski S; Siwek A; Kuder KJ; Latacz G; Kubacka M; Hagenow S; Lubelska A; Olejarz A; Kotańska M; Sadek B; Stark H; Kieć-Kononowicz K
    Eur J Med Chem; 2018 May; 152():223-234. PubMed ID: 29723785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New lead elements for histamine H
    Espinosa-Bustos C; Frank A; Arancibia-Opazo S; Salas CO; Fierro A; Stark H
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2890-2893. PubMed ID: 30025902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H3 receptor inverse agonists.
    Josef KA; Aimone LD; Lyons J; Raddatz R; Hudkins RL
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4198-202. PubMed ID: 22617490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-[(2,3-Dihydro-1-benzofuran-2-yl) methyl]piperazines as novel anti-inflammatory compounds: Synthesis and evaluation on H
    Corrêa MF; Varela MT; Balbino AM; Torrecilhas AC; Landgraf RG; Troncone LRP; Fernandes JPDS
    Chem Biol Drug Des; 2017 Aug; 90(2):317-322. PubMed ID: 28109127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.
    Ishikawa M; Watanabe T; Kudo T; Yokoyama F; Yamauchi M; Kato K; Kakui N; Sato Y
    J Med Chem; 2010 Sep; 53(17):6445-56. PubMed ID: 20690643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.
    Hammer SG; Gobleder S; Naporra F; Wittmann HJ; Elz S; Heinrich MR; Strasser A
    Bioorg Med Chem Lett; 2016 Jan; 26(2):292-300. PubMed ID: 26718844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficient Approaches to S-alkyl-N-alkylisothioureas and Application to Novel Histamine H3R Antagonists].
    Yoneyama H; Yamamoto D; Yamatodani A; Harusawa S
    Yakugaku Zasshi; 2016; 136(9):1217-32. PubMed ID: 27592826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azole derivatives as histamine H3 receptor antagonists, part I: thiazol-2-yl ethers.
    Walter M; von Coburg Y; Isensee K; Sander K; Ligneau X; Camelin JC; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5879-82. PubMed ID: 20728354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization and preclinical evaluation of novel histamine H
    Szczepańska K; Karcz T; Kotańska M; Siwek A; Kuder KJ; Latacz G; Mogilski S; Hagenow S; Lubelska A; Sobolewski M; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2018 Dec; 26(23-24):6056-6066. PubMed ID: 30448256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.
    Lim HD; van Rijn RM; Ling P; Bakker RA; Thurmond RL; Leurs R
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1310-21. PubMed ID: 15947036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
    Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
    Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.
    Sadek B; Schwed JS; Subramanian D; Weizel L; Walter M; Adem A; Stark H
    Eur J Med Chem; 2014 Apr; 77():269-79. PubMed ID: 24650714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-imidazole histamine H3 ligands, part IV: SAR of 1-[2-thiazol-5-yl-(2-aminoethyl)]-4-n-propylpiperazine derivatives.
    Frymarkiewicz A; Walczyński K
    Eur J Med Chem; 2009 Apr; 44(4):1674-81. PubMed ID: 18990469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based prediction of subtype selectivity of histamine H3 receptor selective antagonists in clinical trials.
    Kim SK; Fristrup P; Abrol R; Goddard WA
    J Chem Inf Model; 2011 Dec; 51(12):3262-74. PubMed ID: 22035233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural modifications in the distal, regulatory region of histamine H
    Szczepańska K; Pockes S; Podlewska S; Höring C; Mika K; Latacz G; Bednarski M; Siwek A; Karcz T; Nagl M; Bresinsky M; Mönnich D; Seibel U; Kuder KJ; Kotańska M; Stark H; Elz S; Kieć-Kononowicz K
    Eur J Med Chem; 2021 Mar; 213():113041. PubMed ID: 33261900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies.
    Lim HD; Istyastono EP; van de Stolpe A; Romeo G; Gobbi S; Schepers M; Lahaye R; Menge WM; Zuiderveld OP; Jongejan A; Smits RA; Bakker RA; Haaksma EE; Leurs R; de Esch IJ
    Bioorg Med Chem; 2009 Jun; 17(11):3987-94. PubMed ID: 19414267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel potent (dihydro)benzofuranyl piperazines as human histamine receptor ligands - Functional characterization and modeling studies on H
    Corrêa MF; Balico-Silva AL; Kiss DJ; Fernandes GAB; Maraschin JC; Parreiras-E-Silva LT; Varela MT; Simões SC; Bouvier M; Keserű GM; Costa-Neto CM; Fernandes JPS
    Bioorg Med Chem; 2021 Jan; 30():115924. PubMed ID: 33333448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.